Tenaya Therapeutics, Inc. (TNYA)
Nasdaq: TNYA · Biological Products, (No Diagnostic Substances) · South San Francisco, CA · filing with the SEC since 2021
Who runs Tenaya Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Ali Faraz
Chief Executive Officer. First filing Jul 2021, latest Sep 11, 2026, 10 filings in all.
Officers reporting now
4
of 11 people with a filing in the last fifteen months
Directors reporting now
7
19 people on the record since 2021
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Ali Faraz | Chief Executive Officer | Jul 2021 | Sep 11, 2026 | 9 · $0.00 |
| Tingley Whittemore | Chief Medical Officer | Jul 2021 | Sep 11, 2026 | 9 · $0.00 |
| Hyllengren Eric J | Chief Financial Officer | Jul 2026 | Jul 14, 2026 | none |
| Higa Tomohiro | SVP, Finance | Feb 2025 | May 19, 2026 | 5 · $0.00 |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Burroughs Amy L. | director | Dec 2022 | May 29, 2026 | none |
| Lee June | director | Nov 2021 | May 29, 2026 | none |
| Parschauer Karah Herdman | director | Dec 2021 | May 29, 2026 | none |
| Srivastava Deepak | director | Jul 2021 | May 29, 2026 | none |
| Stehman-Breen Catherine | director | Jul 2021 | May 29, 2026 | none |
| Walsh Jeffrey T. | director | Jul 2021 | May 29, 2026 | none |
| Williams R Sanders | director | Jul 2021 | May 29, 2026 | none |
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Column Group III Gp, LP | 10% owner | Jul 2021 | Feb 26, 2026 | none |
| Column Group III-A, LP | 10% owner | Jul 2021 | Feb 26, 2026 | 8 · $3.5M |
| Column Group III, LP | 10% owner | Jul 2021 | Feb 26, 2026 | none |
| Column Group Opportunity III Gp, LP | 10% owner | Nov 2022 | Feb 26, 2026 | none |
| Column Group Opportunity III, LP | 10% owner | Nov 2022 | Feb 26, 2026 | none |
| Kutzkey Tim | 10% owner | Feb 2026 | Feb 26, 2026 | none |
| Svennilson Peter | 10% owner | Feb 2026 | Feb 26, 2026 | none |
| Tcg Opportunity III Gp, LLC | 10% owner | Nov 2022 | Feb 26, 2026 | 4 · $2.4M |
Earlier names on the record11, newest filing first
Goeddel David V · director · last filing May 2025Saito Chihiro · officer · last filing Nov 2024Hoey Timothy · officer · last filing Mar 2024Patterson Leone D · officer · last filing Feb 2024Chen Jin-Long · director · last filing Jun 2023Casdin Capital, LLC · director · last filing Nov 2022Casdin Eli · director · last filing Nov 2022Kang Jeenjoo · director · last filing Aug 2021Casdin Partners Master Fund, L.P. · 10% owner · last filing Aug 2021Casdin Private Growth Equity Fund Gp, LLC · 10% owner · last filing Aug 2021Casdin Private Growth Equity Fund, L.P. · 10% owner · last filing Aug 2021
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.